Select TransactionsSee More Transactions »

Acquisition by Ligand

Series B Preferred Stock

Spinout from Mount Sinai Health System

Partnership with AstraZeneca

Fairness Opinion

Merger with Daré

Acquisition of Zoladex

Merger with Capnia

Acquisition of Performance Optics

Aquilo Partners is a life science investment bank specializing in mergers & acquisitions, licensing/partnership transactions and private placements. On each transaction, we devote a senior team of bankers committed to a transparent, thoughtful approach to success. Our collective life science banking experience includes:

  • Advising on more than $15 billion in M&A and partnering transactions; raising over $8 billion in capital

  • Maintaining top-tier relationships throughout the global life science industry
  • Biotechnology, big pharma, specialty pharma, medical devices, research tools and diagnostics